BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
90 hedge funds and large institutions have $38.5M invested in BRAINSTORM CELL THERAPUTC in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 27 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
13% less call options, than puts
Call options by funds: $4.5M | Put options by funds: $5.17M
67% less capital invested
Capital invested by funds: $115M → $38.5M (-$76.5M)
Holders
90
Holding in Top 10
–
Calls
$4.5M
Puts
$5.17M
Top Buyers
| 1 | +$1.73M | |
| 2 | +$1.68M | |
| 3 | +$1.23M | |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$799K |
| 5 |
Morgan Stanley
New York
|
+$477K |
Top Sellers
| 1 | -$6.24M | |
| 2 | -$1.08M | |
| 3 | -$728K | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$386K |
| 5 |
SG Americas Securities
New York
|
-$385K |